New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
4 hedge funds and large institutions have $6.71M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0.8% more ownership
Funds ownership: 90% → 90.8% (+0.8%)
5% less capital invested
Capital invested by funds: $7.07M → $6.71M (-$353K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AssetMark Inc
Concord,
California
|
+$47.7K |
| 2 |
GS
GTS Securities
Miami,
Florida
|
+$15.4K |
Top Sellers
LRND Hedge Fund Activity: Q1 2025 in Review
4 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q1 2025, worth a combined $6.71M — down 5% from $7.07M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LRND positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was AssetMark Inc, opening a new position worth an estimated $47.7K.
- 4 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q1 2025, up from 3 in Q4 2024.
- Funds reported $6.71M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q1 2025, down 5% quarter-over-quarter.
- 1 fund opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q1 2025 and 0 closed out, a net change of +1 holder.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF buyer in Q1 2025 was AssetMark Inc, an estimated $47.7K added.
Based on aggregated 13F filings for Q1 2025.